STRS Ohio’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

STRS Ohio’s Portfolio NBSE Stock Details NBSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-220	Closed	-$30K	–	2302
2020 Q4	$30K	Hold	220	–	–	﹤0.01%	2046
2020 Q3	$33K	Hold	220	–	–	﹤0.01%	2031
2020 Q2	$38K	Buy	+220	New	+$36.8K	﹤0.01%	1951
2014 Q4	–	Sell	-18	Closed	-$52K	–	1826
2014 Q3	$52K	Hold	18	–	–	﹤0.01%	1641
2014 Q2	$68K	Buy	+18	New	+$67.8K	﹤0.01%	1594

Other funds holding NBSE

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PCM

Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JAMONY

Jacob Asset Management of New York Hermosa Beach, California $70.9M AUM 14.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

STRS Ohio's NBSE Position: Q1 2021 in Review

STRS Ohio sold out of NeuBase Therapeutics, Inc. Common Stock (NBSE) in Q1 2021, closing a stake of 220 shares — an estimated $30K sold.

STRS Ohio first reported a position in NBSE in Q2 2014 and held it in 5 quarters. The position peaked at $68K in Q2 2014. 56 funds tracked by Wall St. Rank hold NBSE as of Q1 2021.

STRS Ohio reported no remaining NeuBase Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
STRS Ohio sold 220 NeuBase Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $30K.
STRS Ohio first reported a position in NeuBase Therapeutics, Inc. Common Stock in Q2 2014 and held it in 5 quarters.
STRS Ohio's NeuBase Therapeutics, Inc. Common Stock position peaked at $68K in Q2 2014.
56 funds tracked by Wall St. Rank held NeuBase Therapeutics, Inc. Common Stock as of Q1 2021.

Based on STRS Ohio's 13F filing for Q1 2021, filed 23 Apr 2021.